For gliomas, in contrast, new research has shown that ZEB1 loss increases glioma stem cell tumorigenicity and resistance to chemoradiation, and ZEB1 deletion is associated with shorter patient survival [32]. The gene discussed is ZEB1; the disease is glioma.